These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36894866)

  • 41. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003715. PubMed ID: 27681657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Budesonide for maintenance of remission in Crohn's disease.
    Benchimol EI; Seow CH; Otley AR; Steinhart AH
    Cochrane Database Syst Rev; 2009 Jan; (1):CD002913. PubMed ID: 19160212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
    Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
    Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
    Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
    Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.
    Singh S; Andersen NN; Andersson M; Loftus EV; Jess T
    Aliment Pharmacol Ther; 2018 Mar; 47(5):596-604. PubMed ID: 29239001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study.
    Jairath V; Hokkanen SRK; Guizzetti L; Boxall N; Campbell-Hill S; Patel H
    Aliment Pharmacol Ther; 2019 Aug; 50(4):416-424. PubMed ID: 31298421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.
    Ren J; Wu X; Liao N; Wang G; Fan C; Liu S; Ren H; Zhao Y; Li J
    J Int Med Res; 2013 Feb; 41(1):176-87. PubMed ID: 23569144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study.
    Wan J; Wang X; Zhang Y; Xue X; Li Y; Liu Z; Han S; Chen M; Nie Y; Shi Y; Liang J; Wu K
    Can J Gastroenterol Hepatol; 2021; 2021():1412663. PubMed ID: 34422708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease.
    Noureldin M; Cohen-Mekelburg S; Mahmood A; Stidham R; Higgins PDR; Govani S; Deshpande AR; Waljee AK
    Inflamm Bowel Dis; 2021 Mar; 27(4):516-521. PubMed ID: 32469067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
    Gross V; Andus T; Fischbach W; Weber A; Gierend M; Hartmann F; Schölmerich J
    Z Gastroenterol; 1995 Oct; 33(10):581-4. PubMed ID: 7502549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of children with mild Crohn's disease.
    Sharma Y; Bousvaros A; Liu E; Bender Stern J
    World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn's Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018.
    Gonczi L; Lakatos L; Kurti Z; Golovics PA; Pandur T; David G; Erdelyi Z; Szita I; Lakatos PL
    J Crohns Colitis; 2023 Mar; 17(2):240-248. PubMed ID: 36087109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.